@article{cite_2,
  title = {A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19},
  author = {Y Ray, SR Paul, P Bandopadhyay, R D'Rozario},
  journal = {Nature …},
  year = {2022},
  abstract = {A single center open label phase 2 randomised control trial (Clinical Trial Registry of India No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of passive immunization using convalescent plasma therapy. At the Infectious Diseases and Beleghata General Hospital in Kolkata, India, 80 patients hospitalized with severe COVID-19 disease and fulfilling the inclusion criteria (aged more than 18 years, with either mild ARDS having PaO2/FiO2 200–300 or moderate ARDS having PaO2/FiO2 100–200, not on}
}